Biosynex specializes in the research, development and manufacturing of fast diagnosis tests on membrane support for health professionals (biologists, clinicians, nurses and midwives). Products are used in the tropical diseases, autoimmune diseases, emergency markers and Infectious diseases fields. The company's activity is organized around 5 areas: - manufacturing of diagnosis tests for own account; - sale of diagnosis tests supplied by other manufacturers of semi-finished products; - research and development services for third party; - sale of licenses; - sale of biological reagents.

Employees

397

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Closed - OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

04/09	Biosynex: creditors to vote on financial safeguard plan
06/08	Biosynex hit by cyberattack, operational activity remains intact

Market Cap	1.66Cr 1.93Cr 1.57Cr 1.43Cr 2.68Cr 184.35Cr 2.69Cr 19Cr 7.19Cr 94Cr 7.25Cr 7.09Cr 296.36Cr	P/E 2024	-0.43x	P/E 2025	-0.19x
Enterprise Value	6.98Cr 8.1Cr 6.61Cr 5.99Cr 11Cr 774.12Cr 11Cr 79Cr 30Cr 393.84Cr 30Cr 30Cr 1.24TCr	EV / Sales 2024	0.71x	EV / Sales 2025	0.68x
Free-Float	40.35%	Yield 2024 *	-	Yield 2025	-

04/09	Biosynex: creditors to vote on financial safeguard plan
06/08	Biosynex hit by cyberattack, operational activity remains intact
11/06	Triple update for Biosynex
11/06	An undisclosed buyer acquired Entire internal molecular biology business from Biosynex SA for ?4 million.	CI
25/05	Paris climbs on hopes of Middle East de-escalation
25/05	Biosynex announces the divestment of its molecular biology business
25/05	An undisclosed buyer signed a binding offer to acquire Entire internal molecular biology business from Biosynex SA for ?4 million.	CI
08/05	Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
07/05	Biosynex SA Auditor Raises 'Going Concern' Doubt	CI
21/04	Thales, Vivendi, Mercialys, GTT... stocks to watch today in Paris
21/04	Biosynex postpones publication of annual accounts
24/03	Abivax, Ekinops, Sanofi... stocks to watch today in Paris
24/03	Observation period extended for Biosynex

23/24/23	BIOSYNEX SA: CHEMBIO DIAGNOSTICS INC., A SUBSIDIARY OF BIOSYNEX, RECEIVES A GRANT FOR DEVELOPMENT OF A DPP CONGENITAL SYPHILIS ASSAY	EQ
28/23/28	Biosynex Completes Acquisition of Chembio Diagnostics, Inc.	AQ
13/23/13	Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.	AQ
15/23/15	Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.	AQ
01/23/01	Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement	AQ

Biosynex Share Price OTC Markets

Stocks

BSYXF

FR0011005933

Medical Equipment, Supplies & Distribution

Valuation : Biosynex

Latest news : Biosynex

Press Releases : Biosynex

News in other languages : Biosynex

Managers and Directors : Biosynex

Diagnostic & Testing Substances

Financials

Company Profile

04/09	Biosynex : vote des créanciers sur le plan de sauvegarde financière
04/09	BIOSYNEX SA: Notification des créanciers de Biosynex réunis en classes de parties affectées pour voter sur le projet de plan de sauvegarde - Principaux termes du projet de plan de sauvegarde
01/09	Biosynex : Thierry Paper quitte ses fonctions avec effet immédiat
01/09	BIOSYNEX SA: Départ de Monsieur Thierry Paper
07/08	Bourse : Eutelsat souffre, la tech américaine s'offre un baroud d'honneur nocturne

Manager	Title	Age	Since
Larry Abensur CEO	Chief Executive Officer	71	24/06/2015
Thierry Paper CTO	Chief Tech/Sci/R&D Officer	63	01/01/2015
Oren Bitton PRN	Corporate Officer/Principal	-	-

Director	Title	Age	Since
Thierry Paper BRD	Director/Board Member	63	24/06/2015
Thomas Lamy BRD	Director/Board Member	-	24/06/2015
Larry Abensur CHM	Chairman	71	24/06/2015

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BIOSYNEX	-.--%	-.--%	-	-	1.93Cr
GUARDANT HEALTH, INC.	-1.04%	-2.50%	+186.69%	+384.25%	2.11TCr
BIOMÉRIEUX	-1.68%	-5.19%	-38.84%	-22.11%	961.64Cr
10X GENOMICS, INC.	+3.33%	+9.48%	+442.64%	+38.20%	893.8Cr
CARIS LIFE SCIENCES, INC.	+1.25%	-2.91%	-28.54%	-	687.84Cr
LANTHEUS HOLDINGS, INC.	-0.14%	-0.71%	+89.37%	+56.40%	654.45Cr
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	0.00%	-6.45%	-29.52%	-23.10%	564.28Cr
DIASORIN S.P.A.	-0.27%	-2.60%	-7.25%	-19.83%	421.69Cr
ANDON HEALTH CO., LTD.	-1.59%	-9.17%	+56.51%	+67.85%	383.99Cr
AUTOBIO DIAGNOSTICS CO., LTD.	-3.08%	-5.58%	-24.29%	-32.36%	265.24Cr
Average	-0.32%	-2.87%	+71.86%	+56.16%	771.79Cr
Weighted average by Cap.	-0.23%	-2.02%	+113.33%	+137.07%

	2024	2025
Net sales	10Cr 12Cr 9.58Cr 8.68Cr 16Cr 1.12TCr 16Cr 113.77Cr 44Cr 570.7Cr 44Cr 43Cr 1.8TCr	9.52Cr 11Cr 9.01Cr 8.17Cr 15Cr 1.06TCr 15Cr 107.05Cr 41Cr 537Cr 41Cr 41Cr 1.7TCr
Net income	-4.33Cr -5.03Cr -4.1Cr -3.72Cr -6.98Cr -480.47Cr -7.01Cr -49Cr -19Cr -244.44Cr -19Cr -18Cr -772.41Cr	-5.82Cr -6.76Cr -5.51Cr -5Cr -9.37Cr -645.6Cr -9.42Cr -65Cr -25Cr -328.45Cr -25Cr -25Cr -1.04TCr
Net Debt	5.29Cr 6.14Cr 5.01Cr 4.54Cr 8.52Cr 586.96Cr 8.57Cr 60Cr 23Cr 298.62Cr 23Cr 23Cr 943.61Cr	5.32Cr 6.17Cr 5.04Cr 4.56Cr 8.56Cr 589.78Cr 8.61Cr 60Cr 23Cr 300.05Cr 23Cr 23Cr 948.14Cr